Nationwide Children’s spinoff fighting infection in premature babies raises $1.8M

A Nationwide Children’s Hospital spinoff that’s developing a probiotic treatment for the leading cause of death from gastrointestinal disease in premature infants has raised $1.8 million from a group of funds including Rev1 Ventures.

Indianapolis-based Scioto Biosciences Inc. raised the round with Indiana-based BioCrossroads and Elevate Ventures, along with Columbus-based Rev1. It previously had $380,000 in grants from the National Institutes of Health and the state of Indiana.

Click here to read the complete article.

Story excerpt provided by Columbus Business First.

Written by Carrie Ghose.

Originally published May 22, 2018.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: